Yseop Announces Strategic Investment and Celebrates Milestone of 150 Clinical Trials Powered by Generative AI
07 déc. 2023 09h00 HE
|
Yseop
NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Yseop, a world-leading Generative AI company for life sciences, today announces the closing of a strategic investment round, with new investor Novartis...
ODAIA Named Sample Vendor in the GartnerⓇ Hype Cycle™ for Life Science Commercial Operations, 2023
07 sept. 2023 14h03 HE
|
ODAIA
TORONTO , Sept. 07, 2023 (GLOBE NEWSWIRE) -- ODAIA, developers of MAPTUAL, an AI-powered commercial insights SaaS platform for pharmaceutical companies, today announced that it has been listed as a...
ODAIA Adds Demonstrated Industry Talent Following Successful Series B
06 juin 2023 09h00 HE
|
ODAIA
Rebecca Skvorc named Chief Financial OfficerJim Diefenbach named SVP of SalesMike Goulart named Sr. Director, Business Acceleration TORONTO, June 06, 2023 (GLOBE NEWSWIRE) -- ODAIA, developers of...
Yseop Launches “Yseop Copilot,” the World’s Most Secure Digital Colleague for Scientific Writers
06 juin 2023 09h00 HE
|
Yseop
NEW YORK, June 06, 2023 (GLOBE NEWSWIRE) -- Yseop, the world-leading AI software company and pioneer in Generative AI, today announced the launch of Yseop Copilot, the world’s most secure content...
ODAIA Raises $25 Million in Series B Funding to Advance Its AI-Driven Commercial Insights Software for Pharma
01 mai 2023 08h00 HE
|
ODAIA
TORONTO, May 01, 2023 (GLOBE NEWSWIRE) -- ODAIA, developers of MAPTUAL, an AI-powered commercial insights SaaS platform for pharmaceutical companies, today announced it raised an oversubscribed $25...